Recombinant Human Paraneoplastic antigen Ma2(PNMA2),partial CSB-EP018267HUa2
Specifications
| 20ug / 100ug / 1mg price = 100ug |
Alternative Name(s):
40KDA neuronal protein Onconeuronal antigen Ma2 Paraneoplastic neuronal antigen MM2
Species: (Organism)
Homo sapiens (Human)
Gene Names:
PNMA2
Tag info:
N-terminal 6xHis-SUMO-tagged
Target Protein AA Sequence:
ALALLEDWCRIMSVDEQKSLMVTGIPADFEEAEIQEVLQETLKSLGRYRLLGKIFRKQENANAVLLELLEDTDVSAIPSEVQGKGGVWKVIFKTPNQDTEFLERLNLFLEKEGQTVSGMFRALGQEGVSPATVPCISPELLAHLLGQAMAHAPQPLLPMRYRKLRVFSGSAVPAPEEESFEVWLEQATEIVKEWPVTEAEKKRWLAESLRGPALDLMHIVQADNPSISVEECLEAFKQVFGSLESRRTAQVRYLKTYQEEGEKVSAYVLRLETLLRRAVEKRAIPRRIADQVRLEQVMAGATLNQMLWCRLRELKDQGPPPSFLELMKVIREEEEEEASFENESIEEPEERDGYGRWNHE
Expression Region:
2-361aa
Subcellular Location:
Nucleus, nucleolus
Tissue Specificity:
Brain-specific. In some cancer patients, specifically expressed by testicular tumor cells.
Protein Length:
Partial
Pathway:
Mol. Weight:
57.1 kDa
Purity:
Greater than 85% as determined by SDS-PAGE.
Form:
Liquid or Lyophilized powder
Buffer:
If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Research Areas:
Tags & Cell Markers
Function:
Involvement in disease:
Relevance:
Antibodies against PNMA2 are present in sera from patients suffering of paraneoplastic neurological disorders.
Reconstitution:
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Protein Families:
PNMA family
Reference:
"A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer." Voltz R., Gultekin S.H., Rosenfeld M.R., Gerstner E., Eichen J., Posner J.B., Dalmau J. N. Engl. J. Med. 340:1788-1795(1999)
